Multipotent Mesenchymal Stem Cells with Immunosuppressive Activity Can Be Easily Isolated from Dental Pulp
Authors:
- Laura BonsiLBLaura Bonsi
- Mario CalvittiMCMario Calvitti
- Damiano RondelliDRDamiano Rondelli
- Mario ArpinatiMAMario Arpinati
- Gabriella ChirumboloGCGabriella Chirumbolo
- Ennio BecchettiEBEnnio Becchetti
- Cosetta MarchionniCMCosetta Marchionni
- Francesco AlvianoFAFrancesco Alviano
- Valentina FossatiVFValentina Fossati
- Nicola StaffolaniNSNicola Staffolani
- Michele FranchinaMFMichele Franchina
- 27 September 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 80 (6) , 836-842
Abstract
Bone marrow mesenchymal stem cells (MSCs) are currently being investigated in preclinical and clinical settings because of their multipotent differentiative capacity or, alternatively, their immunosuppressive function. The aim of this study was to evaluate dental pulp (DP) as a potential source of MSCs instead of bone marrow (BM). Flow cytometric analysis showed that DP-MSCs and BM-MSCs were equally SH2, SH3, SH4, CD29 and CD 166 positive. The in vitro proliferative kinetics of MSCs were measured by 3H-thymidine incorporation uptake. The immunosuppressive function of MSCs was then tested by coculturing PHA-stimulated allogeneic T cells with or without MSCs for 3 days. BM-MSCs could be differentiated in vitro into osteogenic, chondrogenic and adipogenic lineages. DP-MSCs showed osteogenic and adipocytic differentiation, but did not differentiate into chondrocytes. Although DP-MSCs grow rapidly in vitro between day 3 and day 8 of culture and then decrease their proliferation by day 15, BM-MSCs have a stable and continuous proliferation over the same period of time. The addition of DP-MSCs or BM-MSCs resulted in 91 ± 4% and 75 ± 3% inhibition of T cell response, respectively, assessed by a 3H-thymidine assay. Dental pulp is an easily accessible and efficient source of MSCs, with different kinetics and differentiation potentialities from MSCs as isolated from the bone marrow. The rapid proliferative capacity together with the immunoregulatory characteristics of DP-MSCs may prompt future studies aimed at using these cells in the treatment or prevention of T-cell alloreactivity in hematopoietic or solid organ allogeneic transplantation.Keywords
This publication has 27 references indexed in Scilit:
- Growth factor combination for chondrogenic induction from human mesenchymal stem cellBiochemical and Biophysical Research Communications, 2004
- Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapyJournal of Laboratory and Clinical Medicine, 2004
- Functional characterization of human mesenchymal stem cell-derived adipocytesBiochemical and Biophysical Research Communications, 2003
- Osteoblast recruitment from stem cells does not decrease by age at late adulthoodBiochemical and Biophysical Research Communications, 2003
- One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissuesProceedings of the National Academy of Sciences, 2003
- Reconstruction of Cartilage, Bone, and Hematopoietic Microenvironment with Demineralized Bone Matrix and Bone Marrow CellsStem Cells, 2003
- Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of boneProceedings of the National Academy of Sciences, 2002
- Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoExperimental Hematology, 2002
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Marrow Stromal Cells as Stem Cells for Nonhematopoietic TissuesScience, 1997